BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock
$9,01
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$7–$15
26% of range
Calificación del Analista
BUY
17 analysts
Precio Objetivo
$25
+179% upside
P/E (TTM)
-2.1
ROE
-146.2%
Margen de Beneficio Neto
—
BBOT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$9.01
Capitalización Bursátil
$721M
P/E (TTM)
-2.1
BPA (TTM)
$-4.30
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-146.2%
Deuda/Capital
0.0
Rango 52S
$7 – $15
BBOT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-4.30
2024-12-31
→
2025-12-31
Flujo de caja libre
$-114M
2025-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BBOT
Mediana de Pares
P/E (TTM)
-2.1
70.4
P/B (P/C)
1.8
2.2
EV / EBITDA
-2.0
—
Price / FCF (Precio / FCF)
-6.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BBOT
Mediana de Pares
ROA
-43.8%
-35.6%
ROE
-146.2%
-37.4%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BBOT
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.0
—
Current Ratio (Ratio corriente)
12.3
7.1
Quick Ratio (Ratio Rápido)
12.1
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BBOT
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BBOT
Mediana de Pares
BBOT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
17 analistas
- Compra fuerte 6 35,3%
- Compra 10 58,8%
- Mantener 1 5,9%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
10 analistas · 2026-08-15
Mediana
$23.50
← Por Debajo de Todos los Objetivos
$9.01
Mín
$18.00
Máx
$39.00
Objetivo mediano
$23.50
+160,8%
Objetivo medio
$25.10
+178,6%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.20%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.53 | $-0.54 | 0.01% |
| 31 de diciembre de 2025 | $-0.49 | $-0.53 | 0.04% |
| 30 de septiembre de 2025 | $-1.03 | $-0.40 | -0.63% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| ACHV | — | -4.0 | — | — | — | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $121M | $73M | · | |
| SG&A Expense | $25M | $8M | $41.7K | |
| Operating Expenses | $146M | $81M | · | |
| Operating Income | $-146M | $-81M | $-41.7K | |
| Interest Income | $11M | $6M | · | |
| Other Non-op | $-35.0K | $0 | · | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-134M | $-74M | $-41.7K | |
| EPS (Basic) | $-4.30 | $-5756.41 | · | |
| EPS (Diluted) | $-4.30 | $-5756.41 | · | |
| Shares (Basic) | 31,144,775 | 12,903 | · | |
| Shares (Diluted) | 31,144,775 | 12,903 | · | |
| EBITDA | $-146M | $-584.4K | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $374M | $31M | $0 | |
| Short-term Investments | $52M | $125M | · | |
| Prepaid Expense | $7M | $3M | · | |
| Current Assets | $432M | $159M | · | |
| PP&E (Net) | $956.0K | $490.0K | · | |
| Other Non-current Assets | $13M | $5M | · | |
| Total Assets | $448M | $164M | $332.9K | |
| Accounts Payable | $1M | $3M | · | |
| Accrued Liabilities | · | $119.7K | $15.0K | |
| Short-term Debt | $534.0K | $483.0K | $70.1K | |
| Current Liabilities | $35M | $20M | $396.5K | |
| Capital Leases | $2M | $0 | · | |
| Total Liabilities | $37M | $20M | $396.5K | |
| Total Debt | $534.0K | · | · | |
| Common Stock | $8.0K | $0 | · | |
| Paid-in Capital | $768M | $44M | $24.5K | |
| Retained Earnings | $-357M | $-223M | $-88.6K | |
| AOCI | $16.0K | $348.0K | · | |
| Stockholders' Equity | $411M | $-179M | $-116M | |
| Liabilities + Equity | $448M | $164M | $332.9K | |
| Shares Outstanding | 79,991,768 | 28,415 | · |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | · | |
| Deferred Tax | $0 | $0 | · | |
| Operating Cash Flow | $-114M | $-55M | · | |
| CapEx | $606.0K | $49.0K | · | |
| Investing Cash Flow | $73M | $-121M | · | |
| Stock Issued | $112M | · | · | |
| Net Stock Activity | $112M | · | · | |
| Financing Cash Flow | $383M | $206M | · | |
| Free Cash Flow | $-114M | · | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -43.8% | 7.8% | · | |
| ROE | -146.2% | -9.3% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.3 | 10.4 | · | |
| Quick Ratio | 12.1 | 9.1 | · | |
| Debt / Equity | 0.0 | · | · |
Valoración (TTM) 11
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-134M | $-74M | · | |
| Market Cap | $1.00B | · | · | |
| Enterprise Value | $577M | · | · | |
| P/E | -2.9 | -0.0 | · | |
| P/B | 2.4 | · | · | |
| P / Tangible Book | 2.4 | · | · | |
| P / Cash Flow | -8.8 | · | · | |
| P / FCF | -8.7 | · | · | |
| EV / EBITDA | -4.0 | · | · | |
| EV / FCF | -5.0 | · | · | |
| Earnings Yield | -34.4% | -54823.0% | · |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $49M | $40M | $38M | $35M | $27M | $21M | $20M | $18M | · | · | |
| SG&A Expense | $11M | $6M | $7M | $14M | $3M | $3M | $6M | $2M | $152.3K | $66.7K | |
| Operating Expenses | $60M | $46M | $43M | $49M | $30M | $23M | $22M | $20M | · | · | |
| Operating Income | $-60M | $-46M | $-93M | $-49M | $-30M | $-23M | $-61M | $-20M | $-152.3K | $-66.7K | |
| Interest Income | $4M | $4M | $4M | $3M | $2M | $2M | $255.2K | $2M | $2M | $1M | |
| Other Non-op | $-14.0K | $-94.0K | $-4M | $-30.0K | $-8.0K | $-2.0K | $-4M | $0 | $2M | $1M | |
| Income Tax | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-56M | $-42M | $-39M | $-45M | $-28M | $-22M | $-20M | $-17M | $-22M | $-15M | |
| EPS (Basic) | $-705.20 | $-526.11 | $2.19 | $-1.03 | $-566.46 | $-54.23 | $-833.69 | $-1562.18 | · | · | |
| EPS (Diluted) | $-705.20 | $-526.11 | $2.19 | $-1.03 | $-566.46 | $-54.23 | $-833.69 | $-1562.18 | · | · | |
| Shares (Basic) | 80,054,000 | 80,032 | 16,459,785 | 43,491,085 | 50,198,000 | 406,723 | 1,814 | 11,089 | · | · | |
| Shares (Diluted) | 80,054,000 | 80,032 | 16,459,785 | 43,491,085 | 50,198,000 | 406,723 | 1,814 | 11,089 | · | · | |
| EBITDA | $-60M | $-46M | · | $-49M | $-1M | $-2M | · | $-146.9K | $-152.3K | $-66.7K |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $53M | $374M | $409M | $664.2K | $963.1K | $31M | $2M | $2M | $2M | |
| Short-term Investments | $172M | $200M | $52M | $60M | · | · | $125M | · | · | · | |
| Prepaid Expense | $16M | $14M | $7M | $7M | $62.5K | · | $3M | · | $11.3K | $16.3K | |
| Current Assets | $242M | $267M | $432M | $476M | $876.8K | $1M | $159M | $2M | $2M | $2M | |
| PP&E (Net) | $878.0K | $938.0K | $956.0K | $827.0K | · | · | $490.0K | · | · | · | |
| Other Non-current Assets | $13M | $11M | $13M | $5M | · | · | $5M | · | · | · | |
| Total Assets | $377M | $418M | $448M | $485M | $197M | $196M | $164M | $192M | $190M | $188M | |
| Accounts Payable | $7M | $12M | $1M | $4M | $3M | · | $3M | · | · | · | |
| Accrued Liabilities | · | · | · | · | · | $2M | · | $126.7K | $79.1K | $23.3K | |
| Short-term Debt | · | $716.0K | $534.0K | $691.0K | · | · | $483.0K | · | · | · | |
| Current Liabilities | $52M | $43M | $35M | $36M | $3M | $2M | $20M | $126.7K | $79.1K | $23.3K | |
| Capital Leases | $2M | $2M | $2M | $2M | · | · | $0 | · | · | · | |
| Total Liabilities | $54M | $45M | $37M | $38M | $8M | $7M | $20M | $6M | $6M | $6M | |
| Total Debt | · | $716.0K | · | $691.0K | · | · | · | · | · | · | |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | · | · | $0 | · | · | $51 | |
| Paid-in Capital | $779M | $772M | $768M | $764M | · | · | $44M | · | · | · | |
| Retained Earnings | $-455M | $-399M | $-357M | $-318M | $-7M | $-6M | $-223M | $-4M | $-3M | $-3M | |
| AOCI | $-959.0K | $-981.0K | $16.0K | $36.0K | · | · | $348.0K | · | · | · | |
| Stockholders' Equity | $323M | $372M | $411M | $447M | $-7M | $-6M | $-179M | $-4M | $-3M | $-3M | |
| Liabilities + Equity | $377M | $418M | $448M | $485M | $197M | $196M | $164M | $192M | $190M | $188M | |
| Shares Outstanding | 80,115,002 | 80,088,931 | 79,991,768 | 79,196,710 | · | · | 28,415 | · | · | · |
Flujo de Efectivo 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $4M | $3M | $3M | $36.0K | $627.0K | $4M | $77.4K | $77.4K | $39.4K | |
| Operating Cash Flow | $-44M | $-36M | $-42M | $-71M | $-298.9K | $-20M | $-15M | $-39M | $-29.1K | $-618.0K | |
| CapEx | $47.0K | $24.0K | $73.0K | $140.0K | $231.0K | $162.0K | $10.0K | · | · | · | |
| Investing Cash Flow | $46M | $-285M | $8M | $41M | $10M | $15M | $26M | $38M | $0 | $-184M | |
| Stock Issued | $0 | $112M | $-9M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $112M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $37.0K | $295.0K | $-586.0K | $365M | $19M | $-404.0K | $52.0K | $20M | $0 | $186M | |
| Free Cash Flow | · | $-36M | · | · | · | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | -13.7% | · | -13.2% | 0.47% | -0.25% | · | 2.4% | 2.3% | 1.2% | |
| ROE | -35.8% | -23.0% | · | -20.2% | -17.2% | 10.4% | · | -132.7% | -131.2% | -68.3% |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 6.2 | · | 13.3 | 0.3 | 0.7 | · | 16.1 | 26.2 | 90.4 | |
| Quick Ratio | 4.4 | 5.8 | · | 13.1 | 0.3 | 0.5 | · | 14.1 | 22.9 | 79.0 | |
| Debt / Equity | · | 0.0 | · | 0.0 | · | · | · | · | · | · |
Valoración (TTM) 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-172M | $-137M | · | $-113M | $-90M | $-77M | · | · | · | · | |
| Market Cap | $610M | $717M | · | $917M | · | · | · | · | · | · | |
| Enterprise Value | · | $465M | · | $450M | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.9 | 1.9 | · | 2.1 | · | · | · | · | · | · | |
| P / Tangible Book | 1.9 | 1.9 | · | 2.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | -20.0 | · | · | · | · | · | · | · | · | |
| P / FCF | · | -19.9 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | -10.1 | · | -9.1 | · | · | · | · | · | · | |
| EV / FCF | · | -12.9 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -23606.3% | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Beneficio neto | $-134M | $-74M | $-41.7K |
| EPS Diluido | $-4.30 | $-5756.41 | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Deuda / Patrimonio | 0.0 | — | — |
| Ratio corriente | 12.3 | 10.4 | — |
| Ratio Rápido | 12.1 | 9.1 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-114M | — | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 65 declarantes · $429.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 20 (+3 vs trimestre anterior) | 17 (+10 vs trimestre anterior) | 16 (-3 vs trimestre anterior) | 14 (+3 vs trimestre anterior) | +2.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Cormorant Asset Management, LP | $136 234 886 | 17 878 594 | 31,73% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $37 227 099 | 4 885 446 | 8,67% | Acciones |
| Omega Fund Management, LLC | $25 067 217 | 3 289 661 | 5,84% | Acciones |
| Alphabet Inc. | $21 512 220 | 2 823 126 | 5,01% | Acciones |
| EcoR1 Capital, LLC | $21 512 220 | 2 823 126 | 5,01% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $21 254 481 | 2 789 302 | 4,95% | Acciones |
| ENAVATE SCIENCES GP, LLC | $20 017 329 | 2 626 946 | 4,66% | Acciones |
| CITADEL ADVISORS LLC | $19 269 166 | 2 528 762 | 4,49% | Acciones |
| NOVO HOLDINGS A/S | $17 145 000 | 2 250 000 | 3,99% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $15 283 045 | 2 005 649 | 3,56% | Acciones |
| Laurion Capital Management LP | $15 260 582 | 2 002 701 | 3,55% | Acciones |
| ARMISTICE CAPITAL, LLC | $13 441 680 | 1 764 000 | 3,13% | Acciones |
| STATE STREET CORP | $7 898 656 | 1 036 569 | 1,84% | Acciones |
| Aisling Capital Management LP | $7 757 297 | 1 018 018 | 1,81% | Acciones |
| Opaleye Management Inc. | $5 334 000 | 700 000 | 1,24% | Acciones |
| Granahan Investment Management, LLC | $4 255 968 | 558 526 | 0,99% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 918 497 | 513 932 | 0,91% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $3 512 706 | 460 985 | 0,82% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3 048 000 | 400 000 | 0,71% | Acciones |
| ROYCE & ASSOCIATES LP | $2 933 250 | 384 941 | 0,68% | Acciones |
| Catalio Capital Management, LP | $2 426 261 | 318 407 | 0,57% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 221 398 | 291 522 | 0,52% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 183 267 | 286 518 | 0,51% | Acciones |
| Casdin Capital, LLC | $2 151 217 | 282 312 | 0,50% | Acciones |
| Ensign Peak Advisors, Inc | $2 084 299 | 273 530 | 0,49% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1 872 418 | 244 441 | 0,44% | Acciones |
| FMR LLC | $1 833 235 | 240 582 | 0,43% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 456 578 | 191 152 | 0,34% | Acciones |
| NORTHERN TRUST CORP | $1 230 493 | 161 482 | 0,29% | Acciones |
| Sio Capital Management, LLC | $995 385 | 130 628 | 0,23% | Acciones |
| UBS Group AG | $873 671 | 114 655 | 0,20% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $803 758 | 105 480 | 0,19% | Acciones |
| GOLDMAN SACHS GROUP INC | $777 888 | 102 085 | 0,18% | Acciones |
| MOORE CAPITAL MANAGEMENT, LP | $762 000 | 100 000 | 0,18% | Acciones |
| Brevan Howard Capital Management LP | $690 714 | 88 895 | 0,16% | Acciones |
| Palumbo Wealth Management LLC | $652 455 | 85 624 | 0,15% | Acciones |
| BlackRock, Inc. | $566 867 | 74 392 | 0,13% | Acciones |
| Jump Financial, LLC | $472 440 | 62 000 | 0,11% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $446 532 | 58 600 | 0,10% | Acciones |
| BANK OF AMERICA CORP /DE/ | $409 072 | 53 684 | 0,10% | Acciones |
| Avidity Partners Management LP | $334 160 | 43 853 | 0,08% | Acciones |
| TD Asset Management Inc | $325 603 | 42 730 | 0,08% | Acciones |
| Virtus Investment Advisers, LLC | $321 716 | 42 220 | 0,07% | Acciones |
| VANGUARD GROUP INC | $227 401 | 18 163 | 0,05% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $213 238 | 27 984 | 0,05% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $201 816 | 26 485 | 0,05% | Acciones |
| Rafferty Asset Management, LLC | $172 258 | 22 606 | 0,04% | Acciones |
| CITIGROUP INC | $151 425 | 19 872 | 0,04% | Acciones |
| Squarepoint Ops LLC | $149 824 | 19 662 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $138 402 | 18 163 | 0,03% | Acciones |
| Schonfeld Strategic Advisors LLC | $87 659 | 11 504 | 0,02% | Acciones |
| PROFUND ADVISORS LLC | $83 828 | 11 001 | 0,02% | Acciones |
| AXQ CAPITAL, LP | $81 747 | 10 728 | 0,02% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20 115 | 2 626 | 0,00% | Acciones |
| BARCLAYS PLC | $15 827 | 2 077 | 0,00% | Acciones |
| Tower Research Capital LLC (TRC) | $12 924 | 1 696 | 0,00% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $10 287 | 1 350 | 0,00% | Acciones |
| Rockefeller Capital Management L.P. | $7 620 | 1 000 | 0,00% | Acciones |
| Integrated Wealth Concepts LLC | $3 330 | 437 | 0,00% | Acciones |
| MORGAN STANLEY | $2 286 | 300 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $2 286 | 300 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2 286 | 300 000 | 0,00% | Acciones |
| Quarry LP | $1 501 | 197 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $282 | 37 | 0,00% | Acciones |
| Pacer Advisors, Inc. | $3 | 378 | 0,00% | Acciones |
Informantes de la empresa 17 insiders · 5 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Pedro Beltran | President and CEO | 1 de julio de 2026 F | 44 576 | 0 | 0 | $0 |
| Eli M. Wallace | Chief Executive Officer | 1 de enero de 2026 A | — | 0 | 0 | $0 |
| Idan Elmelech | COO & Principal Financial Ofcr | 1 de julio de 2026 F | 14 495 | 0 | 0 | $0 |
| Yong Ben | Chief Med & Dev Officer | 1 de julio de 2026 F | 44 576 | 0 | 0 | $0 |
| Marc Cobo | Principal Accounting Officer | 1 de julio de 2026 F | 5 306 | 0 | 0 | $0 |
| Chen Bihua | Consejero | 1 de julio de 2026 J | 6 083 221 | 0 | 0 | $0 |
| Peter F Lebowitz | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Raymond J. Kelleher | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Praveen P. Tipirneni | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Neil Kumar | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Jake Bauer | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Frank Mccormick | Consejero | 16 de junio de 2026 A | — | 0 | 0 | $0 |
| Helix Holdings II LLC | Consejero | 8 de febrero de 2025 J | 509 000 | 0 | 0 | $0 |
| Uneek Mehra | — | 1 de abril de 2026 F | 22 806 | 0 | 0 | $0 |
| Albert A Holman III | — | 11 de agosto de 2025 M | 30 000 | 0 | 0 | $0 |
| Mark C. Mckenna | — | 11 de agosto de 2025 M | 30 000 | 0 | 0 | $0 |
| John P. Schmid | — | 11 de agosto de 2025 M | 30 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Bihua Chen, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare Fund V, LP, Cormorant Private Healthcare GP V, LLC, Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Helix Holdings II LLC | 6 de julio de 2026 | 22,32% | Enmienda | — | SEC |
| BridgeBio Pharma LLC, BridgeBio Pharma, Inc. | 18 de agosto de 2025 | 17,50% | Presentación inicial | — | SEC |
| Helix Holdings II LLC, Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Bihua Chen ×3 presentaciones | 13 de agosto de 2025 | 22,60% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 6 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 0,48% | 93 339 NS | 31 de mayo de 2026 | N-PORT |
| IBB · iShares Trust | 0,03% | 316 264 SH | 8 de agosto de 2026 | Diario |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 227 258 NS | 31 de mayo de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27 500 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 549 132 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 422 900 SH | 8 de agosto de 2026 | Diario |